PUBLISHER: The Business Research Company | PRODUCT CODE: 1811043
PUBLISHER: The Business Research Company | PRODUCT CODE: 1811043
Polypropylene surgical mesh is a medical device made from a synthetic plastic polymer that does not dissolve in the body. It is widely utilized in surgical procedures to provide support and strengthen tissues that are weak or injured. The mesh is created to be compatible with the body, strong, and porous, which helps tissues grow into it while preserving its firmness.
The several varieties of polypropylene mesh used in surgery, including monofilament, multifilament, and composite types. Monofilament mesh consists of single continuous strands, which provide excellent strength and lower the chance of infection since bacteria have fewer places to hide. This mesh comes in both absorbable and nonabsorbable forms, and it can be coated or uncoated. It is applied in various medical fields such as hernia fixes, pelvic floor treatments, abdominal procedures, and heart surgeries, serving many healthcare facilities like hospitals and specialty clinics.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The surgical polypropylene mesh market research report is one of a series of new reports from The Business Research Company that provides surgical polypropylene mesh market statistics, including surgical polypropylene mesh industry global market size, regional shares, competitors with a surgical polypropylene mesh market share, detailed surgical polypropylene mesh market segments, market trends and opportunities, and any further data you may need to thrive in the surgical polypropylene mesh industry. This surgical polypropylene mesh market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The surgical polypropylene mesh market size has grown strongly in recent years. It will grow from $2.29 billion in 2024 to $2.44 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The increase during the historic period is linked to a higher occurrence of hernias, an aging population, more surgical operations being performed, the use of synthetic mesh in general surgeries, and a rise in postoperative complications.
The surgical polypropylene mesh market size is expected to see strong growth in the next few years. It will grow to $3.11 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. Growth during the forecast period is driven by a growing preference for minimally invasive hernia repairs, higher demand for durable yet lightweight mesh, broader reimbursement for hernia procedures, increased emphasis on patient-specific treatments, and more cases of abdominal wall reconstruction. Key trends expected include advances in mesh technology, the creation of biocompatible and hybrid meshes, increased research and development in surgical materials, innovations in coating and absorption methods, and the expanding use of 3D printing to produce custom meshes.
The rising incidence of hernias is expected to drive the growth of the surgical polypropylene mesh market in the coming years. Hernias occur when an internal organ or tissue pushes through a weak area in the surrounding muscle or connective tissue, often causing visible bulges and discomfort. The increase in hernia cases is linked to the global rise in obesity rates, which exert additional pressure on the abdominal walls, making them more prone to hernias. This trend is further fueled by sedentary lifestyles and higher consumption of processed foods. Surgical polypropylene mesh provides a solution by offering durable, biocompatible implants that reinforce weakened tissues and support effective long-term repairs. For example, the National Institutes of Health (NIH) in the US projected in April 2025 that hernia cases would increase from 2,764,122 in 2022 to 3,309,718 by 2050, representing a 19.7% rise and an average annual growth rate of 0.64%. Hence, the growing number of hernia cases is boosting the demand for surgical polypropylene mesh.
Leading companies in the surgical polypropylene mesh market are prioritizing the acquisition of regulatory approvals to improve product safety and facilitate market entry. Regulatory approvals are official permissions granted by government or regulatory agencies to confirm that a product complies with required safety, quality, and performance standards before being marketed or used in medical procedures. For instance, in April 2022, Ariste Medical, LLC, a US-based developer of drug-eluting surgical implants, received FDA 510(k) clearance for its innovative drug-embedded synthetic hernia mesh designed to lower the risk of microbial colonization during hernia repair surgeries. Made from polypropylene and infused with antibiotics minocycline and rifampin, the mesh targets bacterial pathogens such as MRSA and E. coli, which commonly cause post-surgical infections. Ventral hernia repair, one of the most frequently performed surgeries in the US, faces infection rates ranging from 8% to 40%, often resulting in costly reoperations and complications for patients.
In December 2022, Integra LifeSciences Holdings Corporation, a US-based medical technology firm, acquired Surgical Innovation Associates for an undisclosed sum. Through this acquisition, Integra LifeSciences aims to strengthen its global strategy in breast reconstruction by increasing access to the US market and enhancing its portfolio of plastic and reconstructive surgical solutions. Integra LifeSciences specializes in developing and selling implantable polymeric surgical devices for plastic, reconstructive, and general surgery, including surgical polypropylene mesh.
Major players in the surgical polypropylene mesh market are Johnson & Johnson, Medtronic Plc, Boston Scientific Corporation, W. L. Gore & Associates Inc., Coloplast A/S, B. Braun Melsungen Aktiengesellschaft, Sutumed Corporation, Sutures.be SMI, ATEX Technologies Inc., Boz Tibbi Anonim Sirketi, Universal Sutures Inc., Lotus Surgicals Private Limited, Betatech Medikal, C. R. Bard Inc., FAS United Medical Company, Luxsutures LLC, Mesh Suture Inc., Orion Sutures Private Limited, Vital Sutures LLC, VUP Medical a.s., Asia Jarah Pishro Company.
North America was the largest region in the surgical polypropylene mesh market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in surgical polypropylene mesh report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the surgical polypropylene mesh market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The surgical polypropylene mesh market consists of sales of lightweight mesh, heavyweight mesh, macroporous mesh, microporous mesh, and self-gripping mesh. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified.)
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Surgical Polypropylene Mesh Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on surgical polypropylene mesh market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for surgical polypropylene mesh ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The surgical polypropylene mesh market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.